Study Evaluating Safety, Tolerability and Clinical Activity of GSK2857916 in Combination With Pembrolizumab in Subjects With Relapsed/Refractory Multiple Myeloma (RRMM)
PHASE1
This is a phase I/II, single arm, open label, two-part study that will asse...
A Study of Subcutaneous (SC) Pembrolizumab Coformulated With Berahyaluronidase Alfa (MK-3475A) vs Intravenous Pembrolizumab in Adult Participants With Metastatic Non-small Cell Lung Cancer (NSCLC) (MK-3475A-D77)-Japan Extension
PHASE3
This study is to assess the pharmacokinetics (PK) and safety of SC pembroli...
A Study of Subcutaneous (SC) Pembrolizumab Coformulated With Berahyaluronidase Alfa (MK-3475A) vs Intravenous Pembrolizumab in Adult Participants With Metastatic Non-small Cell Lung Cancer (NSCLC) (MK-3475A-D77)
PHASE3
This study is to assess the pharmacokinetics (PK) and safety of SC pembroli...
Status
Active Not Recruiting
Location
St. Joseph's Hospital and Medical Center-Dignity Health Cancer Institute ( Site 0023)